Annette Graven Sams

Title: **Inventor Spotlight: Annette Graven Sams**

Introduction:

Annette Graven Sams is a notable inventor based in Vaerlose, Denmark. She has made significant contributions to the field of medicinal chemistry with her innovative work on thiazole derivatives. With one patent to her name, her research is focused on compounds that serve as potential treatments for various neurological and psychiatric disorders.

Latest Patents:

Annette is the inventor of a patent titled "2-acylaminothiazole derivatives." The invention relates to specific compounds classified under formula I, designed for use as medicaments. These compounds act as A-receptor ligands, providing promising avenues for the treatment of disorders where A-receptors play a critical role. The patent reflects her dedication to advancing medical science and improving patient outcomes.

Career Highlights:

Annette is currently employed at H. Lundbeck A/S, a well-respected company specializing in pharmaceuticals. Her work involves extensive research and development, aimed at creating innovative solutions in the field of mental health and neurology. Throughout her career, she has demonstrated a commitment to advancing knowledge and technology in her industry.

Collaborations:

In her journey as an inventor, Annette has collaborated with distinguished colleagues, including Mogens Larsen and Gitte Kobberoee Mikkelsen. These partnerships have played a vital role in enhancing her research and development efforts, allowing for a rich exchange of ideas and expertise.

Conclusion:

Annette Graven Sams exemplifies the innovative spirit that drives advancements in medicinal chemistry. Her contributions, particularly the patent for 2-acylaminothiazole derivatives, hold great potential for improving treatment options for neurological disorders. As an inventor, she continues to inspire future generations in the realm of science and medicine.